DGCI approves market authorisation of Serum Institute’s Covovax as booster dose

Delhi: The Drugs Controller General of India (DCGI) has approved the market authorisation of Serum Institute of India’s (SII) COVID-19 vaccine Covovax as a heterologous booster dose. This vaccine can be taken as a booster dose by people who have already taken two doses of Covishield or Covaxin.Earlier, the DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021. It was approved for teenagers aged